Cafran Injection 1gm

About Cafran Injection 1gm

Cafran Injection 1gm Uses

• Severe pneumonia and other lower respiratory tract infections
• Bacterial meningitis
• Sepsis and bloodstream infections
• Complicated urinary tract infections
• Intra abdominal infections including peritonitis
• Gonorrhea caused by susceptible strains
• Bone and joint infections
• Skin and soft tissue infections

Cafran Injection 1gm Benefits

• Wide coverage against gram negative and several gram positive bacteria
• Reaches high concentrations in blood and tissues quickly after injection
• Crosses into cerebrospinal fluid, useful for central nervous system infections
• Suitable for hospital use in severe or life threatening infections
• Can be combined with other antibiotics for resistant infections

What Experts Say

Cefotaxime belongs to the third generation cephalosporin group and doctors in Pakistan often choose it for hospitalized patients with serious infections. Its broad spectrum activity makes it useful when the exact bacteria causing an infection is not yet known, especially in emergency settings.

Physicians usually prefer the 1gm strength for adults with moderate to severe infections such as pneumonia, meningitis or abdominal sepsis. Hospital pharmacists monitor kidney function during treatment because the dose needs adjustment in patients with reduced renal clearance.

Infectious disease specialists note that cephalosporin resistance is rising across Pakistani hospitals, so culture and sensitivity testing is encouraged before or during therapy whenever possible. Patients with a known penicillin allergy should inform their doctor before this injection is given, since cross reactivity can occur in a small percentage of people.

Drug Class

• Third generation cephalosporin
• Beta lactam antibiotic

Cafran Injection 1gm formula

• Cefotaxime

Available forms

• Injection

How to use Cafran Injection 1gm?

• This injection is given only by a doctor or trained healthcare worker in a hospital or clinic setting.
• The 1gm vial is usually administered through the intravenous or intramuscular route depending on the infection severity.
• Dosing frequency for adults commonly ranges from every 8 to every 12 hours, adjusted by the prescribing doctor.
• Reconstitution with the correct diluent is required before intramuscular use.
• The full course length is set by the treating physician and should not be shortened even if symptoms improve early.

Drug Interactions

• Probenecid: Raises cefotaxime blood levels by slowing its elimination from the kidneys.
• Aminoglycosides: Combined use can improve infection coverage but raises the risk of kidney toxicity.
• Warfarin and Other Blood Thinners: This antibiotic can increase bleeding risk and INR should be monitored.
• Live Typhoid Vaccine: Antibiotic use can reduce the vaccine effectiveness and should be spaced apart.
• Loop Diuretics: Concurrent use with drugs like furosemide may add to kidney related risks.

Risks and warnings

• Cephalosporin Allergy: This injection is contraindicated in patients with a known hypersensitivity to cefotaxime or other cephalosporins.
• Penicillin Cross Reactivity: Patients with severe penicillin allergy carry a small risk of cross reaction and should be monitored closely.
• Kidney Impairment: Dose adjustment is necessary in patients with reduced kidney function to avoid drug accumulation.
• Pregnancy and Breastfeeding: Use only if the treating doctor considers it clearly necessary, after weighing benefits against risks.
• Prior Gastrointestinal Disease: Caution is needed in patients with a history of colitis linked to antibiotic use.

Cafran Injection 1gm Side Effects

• Pain, redness or swelling at the injection site
• Nausea, vomiting or diarrhea
• Mild skin rash or itching
• Temporary rise in liver enzymes on blood tests
• Headache
• Vaginal itching or yeast infection in some women
• Severe allergic reaction including swelling of the face or throat
• Severe watery or bloody diarrhea linked to Clostridioides difficile colitis
• Unusual bleeding or bruising
• Seizures in patients with kidney impairment given high doses

Storage Conditions

• Unopened vials should be kept below 25 degrees Celsius in a cool, dry place away from direct sunlight.
• Reconstituted solution needs to be used within the time period specified on the pack, usually within a few hours if kept at room temperature.
• Refrigeration extends the usable life of the reconstituted solution for a short additional period.
• The vial should never be frozen.
• All medicines must be kept out of reach of children.